孟加拉国消除麻疹进展——2000-2016年
世界卫生组织东南亚区域2013年设立2020年消除麻疹目标,孟加拉国2014年采纳2018年消除目标。
要点
- MCV1覆盖率从2000年74%升至2016年94%,MCV2从2013年35%升至2016年93%。
- 2016年56%地区未达每10万人口≥2例 discarded 非麻疹非风疹病例的监测目标。
核心结论
- 孟加拉国2000-2016年消除麻疹取得进展,但2016年56%地区未达监测绩效目标,需提高MCV1和MCV2覆盖率至所有地区≥95%、增强病例监测敏感性并确保标本及时运送至国家实验室以助实现消除。
研究设计与样本
- 本报告描述孟加拉国2000-2016年消除麻疹的进展与挑战,数据来源于常规免疫规划、补充免疫活动和麻疹病例监测系统。
主要发现
- MCV1估算覆盖率从2000年74%升至2016年94%。
- MCV2于2012年引入,覆盖率从2013年35%升至2016年93%。
- 报告确诊麻疹发病率从2000年34.2/百万人口降至2016年6.1/百万人口,下降82%。
- 2016年56%地区未达每10万人口≥2例 discarded 非麻疹非风疹病例的监测绩效目标。
关键数值与推荐
- 世界卫生组织推荐的消除麻疹策略包括:每个地区2剂MCV覆盖率达≥95%并维持;建立并维持敏感及时的麻疹病例监测系统达到推荐绩效指标;建立并维持认证的麻疹实验室网络。
临床怎么用
- 原文建议采取额外措施,包括将所有地区MCV1和MCV2覆盖率提高至≥95%、针对难以覆盖人群采取额外策略、提高麻疹病例监测敏感性、确保标本及时运送至国家实验室。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 2013, at the 66th session of the Regional Committee of the World Health Organization (WHO) South-East Asia Region (SEAR), a regional goal was established to eliminate measles and control rubella and congenital rubella syndrome* by 2020 (1). WHO-recommended measles elimination strategies in SEAR countries include 1) achieving and maintaining ≥95% coverage with 2 doses of measles-containing vaccine (MCV) in every district, delivered through the routine immunization program or through supplementary immunization activities (SIAs)†; 2) developing and sustaining a sensitive and timely measles case-based surveillance system that meets targets for recommended performance indicators; and 3) developing and maintaining an accredited measles laboratory network (2). In 2014, Bangladesh, one of 11 countries in SEAR, adopted a national goal for measles elimination by 2018 (2,3). This report describes progress and challenges toward measles elimination in Bangladesh during 2000-2016. Estimated coverage with the first MCV dose (MCV1) increased from 74% in 2000 to 94% in 2016. The second MCV dose (MCV2) was introduced in 2012, and MCV2 coverage increased from 35% in 2013 to 93% in 2016. During 2000-2016, approximately 108.9 million children received MCV during three nationwide SIAs conducted in phases. During 2000-2016, reported confirmed measles incidence decreased 82%, from 34.2 to 6.1 per million population. However, in 2016, 56% of districts did not meet the surveillance performance target of ≥2 discarded nonmeasles, nonrubella cases§ per 100,000 population. Additional measures that include increasing MCV1 and MCV2 coverage to ≥95% in all districts with additional strategies for hard-to-reach populations, increasing sensitivity of measles case-based surveillance, and ensuring timely transport of specimens to the national laboratory will help achieve measles elimination.
引用
- Khanal S, Bohara R, Chacko S, et al. Progress Toward Measles Elimination - Bangladesh, 2000-2016. MMWR Morb Mortal Wkly Rep. 2017. PMID: 28727678. doi:10.15585/mmwr.mm6628a3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。